# Questions and Answers on Informed Consent Elements, 21 CFR § 5025(c):  Guidance for Sponsors, Investigators, and Institutional Review Boards - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/small-entity-compliance-guide/questions-and-answers-on-informed-consent-elements-21-cfr-5025c-guidance-for-sponsors-investigators-and-institutional-review-boards/f08c5611-e030-4503-853b-be8ace821598

> FDA guidance document: Questions and Answers on Informed Consent Elements, 21 CFR § 5025(c):  Guidance for Sponsors, Investigators, and Institutional Review Boards. Issue date: February 01, 2012. Get complete insights and analysis.

---

## Details

- Title: Questions and Answers on Informed Consent Elements, 21 CFR § 5025(c):  Guidance for Sponsors, Investigators, and Institutional Review Boards
- Communication Type: Small Entity Compliance Guide
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2012-02-01
- Last Changed: 2019-04-19

## Related Documents

- [Evaluation of Sex Differences in Clinical Investigations:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/information-sheet/evaluation-of-sex-differences-in-clinical-investigations-guidance-for-industry/92c2b117-2251-40a9-9086-3ebfed65505e)
- [Significant Risk and Nonsignificant Risk Medical Device Studies:  Guidance For IRBs, Clinical Investigators, and Sponsors](https://www.globalkeysolutions.net/guidances/information-sheet/significant-risk-and-nonsignificant-risk-medical-device-studies-guidance-for-irbs-clinical-investigators-and-sponsors/bdf7fe5d-6ac5-437c-ada1-e0c1413282af)
- [Informed Consent:  Guidance for IRBs, Clinical Investigators, and Sponsors](https://www.globalkeysolutions.net/guidances/guidance-document/informed-consent-guidance-for-irbs-clinical-investigators-and-sponsors/282489cf-c0a6-44c7-acff-58b3373fd179)